Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-26 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
filingDate |
2001-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2005-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19d537b429c5d25216810d9aa3d13199 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84c291674d8dae28d802ca9f3ad7108b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c8ab4f070b2f75772575118279ee1d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3605266a5c1953b08f9be3b6b8f71b8 |
publicationDate |
2005-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6924294-B2 |
titleOfInvention |
Excitatory amino acid receptor antagonists |
abstract |
The present invention provides novel compounds of Formula (I), or the pharmaceutically acceptable salts or prodrugs thereof, and methods for treating neurological disorders and neurodegenerative diseases, particularly pain and migraine. |
priorityDate |
2001-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |